Literature DB >> 14301686

II. URINARY EXCRETION OF ESTRONE, ESTRADIOL, AND ESTRIOL BY PATIENTS WITH BREAST CANCER AND BENIGN BREAST DISEASE.

J MARMORSTON, L G CROWLEY, S M MYERS, E STERN, C E HOPKINS.   

Abstract

Entities:  

Keywords:  BREAST DISEASES; BREAST NEOPLASMS; ESTRADIOL; ESTRIOL; ESTROGENS; ESTRONE; MENOPAUSE; METABOLISM; URINE

Mesh：

Substances：

Year:  1965        PMID： 14301686     DOI： 10.1016/s0002-9378(16)34835-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  12 in total

Review 1.  Hormones and neoplasia.

Authors:  A P Forrest
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

Review 2.  Current status of the management of patients with endocrine-sensitive tumors. I. Introduction and carcinoma of the breast.

Authors:  L G Crowley
Journal:  Calif Med       Date:  1969-01

Review 3.  Epidemiology and endocrinology of benign breast disease.

Authors:  D Y Wang; I S Fentiman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 4.  Differentiation of the mammary gland and susceptibility to carcinogenesis.

Authors:  J Russo; L K Tay; I H Russo
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

5.  A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.

Authors:  G Ursin; S London; F Z Stanczyk; E Gentzschein; A Paganini-Hill; R K Ross; M C Pike
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

Review 6.  Endogenous estrogens and breast cancer risk: the case for prospective cohort studies.

Authors:  P G Toniolo
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

7.  A prospective study of urinary oestrogen excretion and breast cancer risk.

Authors:  T J Key; D Y Wang; J B Brown; C Hermon; D S Allen; J W Moore; R D Bulbrook; I S Fentiman; M C Pike
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

Review 8.  Estrogen replacement therapy (ERT) in high-risk cancer patients.

Authors:  K A Hutchinson-Williams; J N Gutmann
Journal:  Yale J Biol Med       Date:  1991 Nov-Dec

Review 9.  Molecular and cellular basis of the mammary gland susceptibility to carcinogenesis.

Authors:  J Russo; L K Tay; D R Ciocca; I H Russo
Journal:  Environ Health Perspect       Date:  1983-03       Impact factor: 9.031

10.  Serum oestradiol-17 beta in normal women.

Authors:  P C England; L G Skinner; K M Cottrell; R A Sellwood
Journal:  Br J Cancer       Date:  1974-06       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.